Friday, November 29, 2019

Gastro Health 2020

About Conference

International Conference on Digestive and Gastroenterology Health Conditions scheduled during July 20-21, 2020 at Barcelona Spain. This Conference focuses on the theme “Novel advancements in Digestive and Gastroenterology”.
Gastro Health 2020 is the best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects.
Conference series LLC Ltd amiably invites the worldwide arena to global researchers, professors, doctors, scientists gastroenterologists, hepatologists, diabetologists, endoscopists, internists, physicians, microbiologists, virologists, pathologists, oncologists, surgeons and toxicologists, students, business delegates and young researchers across the globe to voice their examination discoveries to the world to learn about current and upcoming issues, explore new developments in the field of gastroenterology and interact with others with similar interest.

Market Analysis
Gastroenterology is the branch of medicine focused on the digestive system and its disorders.  Diseases affecting the gastrointestinal tract (GI), which include the organs from mouth into anus, along the alimentary canal. Gastrointestinal diseases refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
The size of the global gastrointestinal therapeutics market is expected to reach USD 13.8 billion by 2020, accelerating at a CAGR of 6.5% between 2015-2020. This growth in market size is attributed to numerous factors including increasing consumption of biologics, tentative approval of late stage molecules, development of novel therapies using innovative technologies, and improved diagnostic tools increasing the treatment-seeking population. 
Additionally, a sudden increase in the number of gastric surgeries across the globe is directly impacting the growth of post-surgical gastro paresis cases across the globe, which will directly propel growth within the gastro paresis drugs market over the next few years. Due to this primary growth factor, the global gastro paresis drugs market will increase USD 940 million between 2016-2021, exceeding USD 7.1 billion in market size by the end of the forecast period. Other factors driving the growth of this market include unmet needs in the industry to increase the R&D in the field and the rising cases of diabetes fueling the prevalence of diabetic gastro paresis.

Conference Highlights
  • Gastro Esophageal Reflux Disease
  • Diverticular Diseases
  • Colon Polyps and cancer
  • Irritable Bowel Syndrome
  • Hemorrhoids
  • Anal Fissure
  • Gallstones
  • Colitis
  • Bariatric Surgery
  • Gastrointestinal Disorders
  • Hepatology
  • Digestive Bleeding
  • Peptic Ulcers
  • Constipation
  • Oesophageal Cancer
  • Gastric Cancer
  • Endoscopy Esophagus
  • Hernia
  • Functional GI Disorders
  • Gastrointestinal Stromal Tumors
  • Diabetes: Types and its Complications

Special Issues
 - All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
 - Abstracts will be provided with Digital Object Identifier by Cross Ref.

  See more at